Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Ambalal Sarabhai Enterprises

AMBASARABH
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Ambalal Sarabhai Enterprises Share price and Fundamental Analysis

View All Details
View All Details
Ambalal Sarabhai Enterprises Ltd produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. The company operates in two segments, namely pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. Their subsidiaries include Synbiotics Ltd, Haryana Containers Ltd, Asence Inc, Asence Pharma Pvt Ltd, Mautik Exim Ltd, Systronics ( I ) Ltd, Suvik Hitek Pvt Ltd and Vovanties Lab Pvt Ltd.
Company Incorporation1977
ChairmanKartikeya V Sarabhai
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
281.7
PE Ratio
28.06
Industry P/E
34.33
PEG Ratio
0.53
ROE
7.16%
ROCE
8.43%
ROA
1.83%
Total Debt (Cr)
7.66
Debt to Equity
0.36
Dividend Yield
0%
EPS
1.31
Book Value & P/B
6.33 x 5.81
Face Value
10
Outstanding Shares(Cr)
7.66
Current Ratio
1.51
EV to Sales
1.64

Included In

+More

Stock Returns

1 Week-0.92%
1 Month-5.57%
6 Months-40.3%
1 Year-17.21%
3 Years+25.25%
5 Years+114.34%

CAGR

1 Year CAGR

Revenue Growth

+1.93%

Net Profit Growth

-48.83%

Operating Profit Growth

-20.72%

Dividend Growth

N/A

Stock Returns CAGR

-17.21%
no_data

No Stocks

Smart Score

1.7
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 31.35%

FIIs : 0.38%

DIIs : 0.10%

Public : 68.17%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
FII Shareholding Increased by 0.38% to 0.38% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Ambalal Sarabhai Enterprises Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Ambalal Sarabhai Enterprises Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Ambalal Sarabhai Enterprises Ltd produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. The company operates in two segments, namely pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. Their subsidiaries include Synbiotics Ltd, Haryana Containers Ltd, Asence Inc, Asence Pharma Pvt Ltd, Mautik Exim Ltd, Systronics ( I ) Ltd, Suvik Hitek Pvt Ltd and Vovanties Lab Pvt Ltd.

Ambalal Sarabhai Enterprises Ltd was incorporated on June 5, 1978. The company became a public limited company in December 1980. In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections.

During the year 1997-98, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 1998-99, the company signed agreement with B V Chiron, Netherlands for introducing their anti-cancer drugs in India.

During the year 1999-2000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The product division essentially comprising of Sarabai Chemicals products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd.

In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division re-launched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd.

During the year 2008-09, the Oncology Division launched two new products viz. Fludagem & Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent drug delivery system.

During the year 2010-11, the company has transferred and assigned as a going concern the undertaking and business of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and electronics division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010.

Ambalal Sarabhai Enterprises Share Price

Ambalal Sarabhai Enterprises share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Ambalal Sarabhai Enterprises Market Cap

Market capitalization of Ambalal Sarabhai Enterprises indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Ambalal Sarabhai Enterprises is valued compared to its competitors.

Ambalal Sarabhai Enterprises PE Ratio

Ambalal Sarabhai Enterprises PE ratio helps investors understand what is the market value of each stock compared to Ambalal Sarabhai Enterprises 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Ambalal Sarabhai Enterprises PEG Ratio

The PEG ratio of Ambalal Sarabhai Enterprises evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Ambalal Sarabhai Enterprises ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Ambalal Sarabhai Enterprises generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Ambalal Sarabhai Enterprises ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Ambalal Sarabhai Enterprises in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Ambalal Sarabhai Enterprises Total Debt

Total debt of Ambalal Sarabhai Enterprises shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Ambalal Sarabhai Enterprises Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Ambalal Sarabhai Enterprises compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Ambalal Sarabhai Enterprises CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Ambalal Sarabhai Enterprises over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Ambalal Sarabhai Enterprises Technical Analysis

Technical analysis of Ambalal Sarabhai Enterprises helps investors get an insight into when they can enter or exit the stock. Key components of Ambalal Sarabhai Enterprises Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Ambalal Sarabhai Enterprises shares often struggle to rise above due to selling pressure.

Ambalal Sarabhai Enterprises Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Ambalal Sarabhai Enterprises ’s financial health and profitability.

Ambalal Sarabhai Enterprises Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Ambalal Sarabhai Enterprises Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Ambalal Sarabhai Enterprises Financials

The financials of Ambalal Sarabhai Enterprises provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Ambalal Sarabhai Enterprises Profit and Loss Statements

The profit and loss statement of Ambalal Sarabhai Enterprises highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Ambalal Sarabhai Enterprises .

Ambalal Sarabhai Enterprises Balance Sheet

The balance sheet presents a snapshot of Ambalal Sarabhai Enterprises ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Ambalal Sarabhai Enterprises Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App